Skip to main content
Awakn Life Sciences Corp. (1169082 BC Ltd.) logo

Awakn Life Sciences Corp. (1169082 BC Ltd.) — Investor Relations & Filings

Ticker · AWKN CSE Manufacturing
Filings indexed 271 across all filing types
Latest filing 2025-05-29 Regulatory Filings
Country CA Canada
Listing CSE AWKN

About Awakn Life Sciences Corp. (1169082 BC Ltd.)

https://www.awaknlifesciences.com

Awakn Life Sciences Corp. is a clinical-stage biotechnology company focused on researching, developing, and commercializing novel therapeutics, including psychedelic medicine, to treat addiction and psychiatric disorders. The company integrates medication-assisted treatments into mainstream healthcare through clinical operations, research, and digital platforms. Awakn's initial therapeutic focus areas are Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD). It is recognized for pioneering evidence-backed ketamine-assisted therapy for AUD. Its discovery programs support expansion across psychiatry and potential entry into neurology.

Recent filings

Filing Released Lang Actions
Decision Document / Order for Application - English.pdf
Regulatory Filings
2025-05-29 English
News release - English.pdf
M&A Activity Classification · 88% confidence The document is a press release announcing the completion of an arrangement under corporate law whereby Solvonis Therapeutics plc acquires all outstanding shares and related securities of Awakn Life Sciences Corp. It details transaction terms, shareholder approvals, and post-closing delisting. This is a classic merger/acquisition announcement, matching the M&A Activity category.
2025-05-27 English
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a press release announcing that at the annual general and special meeting, shareholders overwhelmingly approved a special resolution for a statutory plan of arrangement (M&A transaction). It provides detailed voting results (percentages, class votes) and constitutes an official declaration of shareholder vote outcomes. This fits the Declaration of Voting Results & Voting Rights Announcements category (DVA).
2025-04-23 English
News release - English.pdf
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a supplemental disclosure to the management information circular for a shareholders’ meeting to approve a statutory plan of arrangement. It provides detailed proxy‐related information on “collateral benefits” under MI 61-101 for securityholder voting, which is part of the materials sent to shareholders to inform them and solicit their votes. Therefore, it fits the Proxy Solicitation & Information Statement category (PSI).
2025-04-11 English
Certificate re dissemination to shareholders.pdf
Proxy Solicitation & Information Statement Classification · 80% confidence The document is a confirmation letter from Endeavor Trust Corporation stating that they have mailed the AGM notice, proxy form and related materials to shareholders in advance of the April 22, 2025 Annual & Special Meeting. It is not the full AGM presentation nor an earnings or financial report, but rather the distribution of proxy solicitation materials. The best matching category is Proxy Solicitation & Information Statement (PSI).
2025-03-18 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a formal Notice of Annual General and Special Meeting of securityholders, including proxy and voting instructions, record date, meeting agenda, and refers to the management information circular. It is not the actual AGM presentation nor the final vote results, but the solicitation of votes and information statement for shareholders prior to the meeting. This falls squarely under the “Proxy Solicitation & Information Statement” category (Code: PSI).
2025-03-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.